Human Herpesvirus 6 Clinical Virology

Human herpesvirus 6 (HHV-6) comprises two closely related species, HHV-6A and HHV-6B, that establish lifelong infection in nearly all humans. Following primary infection, typically in early childhood in the case of HHV-6B, the virus enters a latent state within lymphoid and myeloid cells, often integrating into host telomeres. In approximately 1 % of individuals, chromosomal integration occurs in germ cells, producing inherited ciHHV-6 that may reactivate under immunosuppression. Reactivation is associated with a spectrum of clinical syndromes, including pneumonitis, encephalitis and graft dysfunction in transplant recipients. Advances in molecular diagnostics, such as quantitative PCR and RNA-seq, have refined viral load thresholds predictive of disease and clarified host gene expression signatures, notably interferon-driven pathways. Understanding viral latency, integration and reactivation informs risk stratification in transplantation, the management of autoimmune sequelae and the development of targeted antivirals.

Research from Nature Portfolio

Recent studies have illuminated the role of HHV-6B as a pulmonary pathogen after allogeneic haematopoietic cell transplant. By analysing paired blood and bronchoalveolar lavage fluid, investigators defined DNA viral load cut-offs in lavage samples that reliably predict active viral transcription. Patients exceeding these thresholds exhibited interferon-enriched host expression profiles and a markedly increased risk of respiratory failure and mortality. These findings establish quantitative viral markers for clinical decision-making and underscore the importance of vigilant virological surveillance in immunocompromised hosts.

Human Herpesvirus 6 Clinical Virology publication trend

The graph below shows the total number of articles in human herpesvirus 6 clinical virology across all publications each year (not limited to Nature Index journals).

Technical terms

Lytic infection: a phase of viral replication characterised by active production of infectious virions and cell lysis.

Viral latency: a dormant state in which the viral genome persists in host cells with limited gene expression and no virion production.

Bronchoalveolar lavage (BAL): a procedure to sample fluid from the lower respiratory tract for microbiological and molecular analysis.

Telomere integration: insertion of viral DNA into the terminal repeat regions of host chromosomes, facilitating latency and inheritance.

Inherited chromosomally integrated HHV-6 (iciHHV-6): the vertical transmission of a full HHV-6 genome integrated into germline telomeres, present in every cell of an individual.

Viral load threshold: a quantitative cut-off value of viral genome copies used to predict active infection and clinical risk.

References

1. HHV-6B detection and host gene expression implicate HHV-6B as pulmonary pathogen after hematopoietic cell transplant. Nature Communications (2024).
2. Reactivation of a Transplant Recipient's Inherited Human Herpesvirus 6 and Implications to the Graft. The Journal of Infectious Diseases (2024).
3. Inherited Chromosomally Integrated Human Herpesvirus 6: Laboratory and Clinical Features. Microorganisms (2023).
4. Latency, Integration, and Reactivation of Human Herpesvirus-6. Viruses (2017).